Potential barriers to the use of anti-obesity medications in persons with spinal cord injuries and disorders.

Sherri L LaVela Kelsey Berryman Ibuola O Kale Gary J Farkas Geoffrey V Henderson Vanessa Rosales Dan Eisenberg Lorena Reyes

Published in: Obesity science & practice (2024)

There are several potential barriers to AOM use in the SCI/D population. Barriers include AOM side effects which may cause or exacerbate conditions that are already concerns in persons with SCI/D, such as bowel and skin problems, and muscle loss. SCI/D HCPs reported a lack of evidence about AOM use in persons with SCI/D, but interest in obtaining more knowledge.

Keyphrases

spinal cord injury
spinal cord
neuropathic pain
metabolic syndrome
healthcare
mental health
insulin resistance
human health
soft tissue
physical activity
adipose tissue
weight gain
high fat diet induced
climate change